Stock Events

Stock Events

Adhera Therapeutics 

$0
2
+$0+0% Thursday 20:00

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
84,001
Avg. Volume
1,581
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.57
-0.38
-0.19
0
Expected EPS
0
Actual EPS
-0.57

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-5.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATRX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech company that develops treatments in areas that may overlap with Adhera's focus on cardiovascular diseases, making them direct competitors in the biopharmaceutical market.
Pfizer
PFE
Mkt Cap140.15B
Pfizer operates in various therapeutic areas, including cardiovascular health, directly competing with Adhera Therapeutics in the pharmaceutical market.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that offers products in multiple segments, including cardiovascular, competing with Adhera's product offerings.
Merck
MRK
Mkt Cap214.76B
Merck is known for its wide range of pharmaceutical products, including treatments for cardiovascular diseases, positioning it as a competitor to Adhera Therapeutics.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences focuses on life-threatening diseases, including cardiovascular conditions, making it a competitor in the same therapeutic area as Adhera.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in various therapeutic areas, including cardiovascular health, competing with Adhera Therapeutics in the biopharmaceutical space.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb offers a range of prescription medicines, including those for cardiovascular diseases, directly competing with Adhera Therapeutics.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is involved in the discovery, development, and commercialization of prescription medicines, including for cardiovascular diseases, making it a competitor to Adhera.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical segment, develops treatments for various diseases, including cardiovascular, competing with Adhera Therapeutics.
Sanofi
SNY
Mkt Cap124.45B
Sanofi focuses on healthcare solutions, including cardiovascular diseases, positioning it as a competitor in the same market as Adhera Therapeutics.

About

Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Show more...
CEO
Mr. Andrew Albert Kucharchuk M.B.A.
Employees
2
Country
US
ISIN
US00687E4061

Listings

OTC Link
US
ATRX

0 Comments

Share your thoughts

FAQ

What is Adhera Therapeutics stock price today?▼
The current price of ATRX is $0 USD — it has increased by +0% in the past 24 hours. Watch Adhera Therapeutics stock price performance more closely on the chart.
What is Adhera Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adhera Therapeutics stocks are traded under the ticker ATRX.
What were Adhera Therapeutics earnings last quarter?▼
ATRX earnings for the last quarter are -0.57 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Adhera Therapeutics revenue for the last year?▼
Adhera Therapeutics revenue for the last year amounts to 0 USD.
What is Adhera Therapeutics net income for the last year?▼
ATRX net income for the last year is -5.47M USD.
How many employees does Adhera Therapeutics have?▼
As of April 01, 2026, the company has 2 employees.
In which sector is Adhera Therapeutics located?▼
Adhera Therapeutics operates in the Health Care sector.
When did Adhera Therapeutics complete a stock split?▼
The last stock split for Adhera Therapeutics was on October 06, 2022 with a ratio of 1:20.
Where is Adhera Therapeutics headquartered?▼
Adhera Therapeutics is headquartered in Baton Rouge, US.